Valganciclovir as Add-on to Standard Therapy in Glioblastoma Patients

Abstract

Valganciclovir prolonged median OS of patients with newly diagnosed glioblastoma (with methylated or unmethylated <i>MGMT</i> promoter gene) and was safe to use.